Levodexa 0.1 % (Dexamethasone (Dexamethasone Sodium Phosphate) SOLUTION) 0.1 %

Levodexa 0.1% is an ophthalmic solution containing dexamethasone sodium phosphate. It is commonly used for eye conditions requiring anti-inflammatory or anti-allergic treatment. This steroid solution helps reduce eye redness, swelling, and itching.

Strength

0.1 %

Manufacturer / TM Owner

XEDITON PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Levodexa 0.1% is primarily used for the treatment of eye inflammation and allergic reactions. It is often prescribed for conditions such as conjunctivitis, uveitis, and other inflammatory eye disorders. The solution helps alleviate symptoms like redness, swelling, and itching, providing relief for various eye irritations.

Side Effects

Common effects of Levodexa 0.1% may include temporary stinging or burning upon application. Some users might experience blurred vision or increased sensitivity to light. These effects are usually mild and short-lived. If persistent or severe, consult a healthcare professional.

Precautions & Warnings

Levodexa 0.1% should be used with caution in individuals with a history of eye infections or glaucoma. Avoid touching the dropper tip to prevent contamination. Do not use this solution if you are allergic to dexamethasone or any of its components. Always follow the prescribed usage instructions.

Avoid Interactions

Levodexa 0.1% may interact with other eye medications. Inform your healthcare provider about all medications you are currently using. Avoid using this solution with other eye drops unless directed by a healthcare professional. Alcohol and certain medications may also affect the efficacy of Levodexa 0.1%.

Frequently Asked Questions

Levodexa 0.1% is used to treat eye inflammation and allergic reactions, such as conjunctivitis and uveitis.

Follow the instructions provided by your healthcare professional. Typically, a few drops are applied to the affected eye as directed.

Common side effects may include temporary stinging, burning, blurred vision, or increased sensitivity to light.

Consult your healthcare provider before using Levodexa 0.1% with other eye drops to avoid potential interactions.

Long-term use should be monitored by a healthcare professional to avoid potential side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.